14 Stocks With Heavy Insider Buying In 2024
Markets await latest inflation numbers and the debate regarding soft vs hard landing is expected to persist in the Wall Street for months to come.
Astria Therapeutics Inc. (ATXS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 0 | $0 | -100% | 0% |
| 2. | RA Capital Management Peter Kolchinsky | 0 | $0 | -100% | 0% |
| 3. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 0 | $0 | -100% | 0% |
| 4. | AQR Capital Management Cliff Asness | 0 | $0 | -100% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.09 | 2,481,350 | Director | 4,873,721 | 2024-02-01 | Filing | |
| $6.20 | 740,000 | Director | 2,392,371 | 2023-12-21 | Filing | |
| $6.51 | 460,546 | Director | 1,611,699 | 2023-10-16 | Filing | |
| $6.51 | 614,062 | Director | 1,652,371 | 2023-10-16 | Filing | |
| $11.01 | 908,265 | Director | 1,038,309 | 2022-12-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.59 | 10,000 | Officer | 0 | 2024-04-01 | Filing | |
| $11.15 | 9,200 | Officer | 0 | 2024-01-29 | Filing | |
| $11.02 | 800 | Officer | 0 | 2024-01-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Astria Therapeutics, Inc. (NASDAQ:ATXS) Q3 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Astria Therapeutics Quarter Three 2023 Corporate Update. At this time, all attendees are in a listen-only mode.
Astria Therapeutics, Inc. (NASDAQ:ATXS) Q4 2022 Earnings Call Transcript
Operator: Good morning and welcome to the Astria Therapeutics 2022 Q4 and Full Year Financial Results and Business Update Conference Call. At this time, all attendees are in a listen-only mode.
12 Best Performing Biotech Stocks in 2022
Fitch Ratings has assigned a Neutral rating to the global pharmaceutical and biotech industry, which indicates the assumption of a collaborative operating backdrop in 2023, although inflationary pressures...
Hedge Fund and Insider Trading News: Cathie Wood, Karthik Sarma, D.E. Shaw, Alameda Research, Astria Therapeutics, Inc. (ATXS), Dave & Buster's Entertainment, Inc. (PLAY), and More
Cathie Wood’s ARK Innovation Fund, which more than doubled during the pandemic rally, is on pace to finish near the very bottom of all U.S.
10 Best Immunology Stocks to Invest In
Immunology is the study of the immune system of higher organisms in relation to disease.